Vincent Jean-Louis, Kellum John A, Shaw Andrew, Mythen Michael G
Crit Care. 2013 Oct 1;17(5):193. doi: 10.1186/cc13027.
The choice of which intravenous solution to prescribe remains a matter of considerable debate in intensive care units around the world. Trends have been moving away from using hydroxyethyl starch solutions following concerns about safety. But are the available data sufficient to clearly assess the risk-benefit balance for all patients, and is there enough evidence of harm to justify removing these drugs completely from our hospitals?
在全球的重症监护病房中,选择何种静脉输液制剂仍然是一个备受争议的问题。由于对安全性的担忧,使用羟乙基淀粉溶液的趋势已经减弱。但是,现有的数据是否足以明确评估所有患者的风险效益平衡,是否有足够的危害证据来证明将这些药物完全从医院中移除是合理的?